Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

1967
2025

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 4
1968 3
1969 3
1970 7
1971 4
1972 9
1973 4
1975 4
1976 9
1977 3
1978 4
1979 5
1980 4
1981 7
1982 6
1983 3
1984 6
1985 2
1986 2
1987 4
1988 6
1989 7
1990 5
1991 3
1992 4
1993 5
1994 3
1995 9
1996 3
1997 11
1998 1
1999 8
2000 8
2001 10
2002 7
2003 5
2004 3
2005 5
2006 13
2007 8
2008 4
2009 2
2010 7
2011 4
2012 8
2013 5
2014 3
2015 11
2016 9
2017 10
2018 12
2019 11
2020 11
2021 13
2022 5
2023 11
2024 5
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

326 results

Results by year

Filters applied: . Clear all
Page 1
Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement.
Mantovani G, Bastepe M, Monk D, de Sanctis L, Thiele S, Usardi A, Ahmed SF, Bufo R, Choplin T, De Filippo G, Devernois G, Eggermann T, Elli FM, Freson K, García Ramirez A, Germain-Lee EL, Groussin L, Hamdy N, Hanna P, Hiort O, Jüppner H, Kamenický P, Knight N, Kottler ML, Le Norcy E, Lecumberri B, Levine MA, Mäkitie O, Martin R, Martos-Moreno GÁ, Minagawa M, Murray P, Pereda A, Pignolo R, Rejnmark L, Rodado R, Rothenbuhler A, Saraff V, Shoemaker AH, Shore EM, Silve C, Turan S, Woods P, Zillikens MC, Perez de Nanclares G, Linglart A. Mantovani G, et al. Nat Rev Endocrinol. 2018 Aug;14(8):476-500. doi: 10.1038/s41574-018-0042-0. Nat Rev Endocrinol. 2018. PMID: 29959430 Free PMC article. Review.
This Consensus Statement covers recommendations for the diagnosis and management of patients with pseudohypoparathyroidism (PHP) and related disorders, which comprise metabolic disorders characterized by physical findings that variably include short bones, short stature, a …
This Consensus Statement covers recommendations for the diagnosis and management of patients with pseudohypoparathyroidism (PHP) and …
Pseudohypoparathyroidism.
Linglart A, Levine MA, Jüppner H. Linglart A, et al. Endocrinol Metab Clin North Am. 2018 Dec;47(4):865-888. doi: 10.1016/j.ecl.2018.07.011. Epub 2018 Oct 12. Endocrinol Metab Clin North Am. 2018. PMID: 30390819 Free PMC article. Review.
Pseudohypoparathyroidism (PHP) refers to a heterogeneous group of uncommon, yet related metabolic disorders that are characterized by impaired activation of the Gsalpha/cAMP/PKA signaling pathway by parathyroid hormone (PTH) and other hormones that interact with Gsa-couple
Pseudohypoparathyroidism (PHP) refers to a heterogeneous group of uncommon, yet related metabolic disorders that are characterized by
Molecular Definition of Pseudohypoparathyroidism Variants.
Jüppner H. Jüppner H. J Clin Endocrinol Metab. 2021 May 13;106(6):1541-1552. doi: 10.1210/clinem/dgab060. J Clin Endocrinol Metab. 2021. PMID: 33529330 Free PMC article. Review.
Pseudohypoparathyroidism (PHP) and pseudopseudohypoparathyroidism (PPHP) are caused by mutations and/or epigenetic changes at the complex GNAS locus on chromosome 20q13.3 that undergoes parent-specific methylation changes at several differentially methylated regions (DMRs)
Pseudohypoparathyroidism (PHP) and pseudopseudohypoparathyroidism (PPHP) are caused by mutations and/or epigenetic changes at the com
Recommendations for Diagnosis and Treatment of Pseudohypoparathyroidism and Related Disorders: An Updated Practical Tool for Physicians and Patients.
Mantovani G, Bastepe M, Monk D, de Sanctis L, Thiele S, Ahmed SF, Bufo R, Choplin T, De Filippo G, Devernois G, Eggermann T, Elli FM, Garcia Ramirez A, Germain-Lee EL, Groussin L, Hamdy NAT, Hanna P, Hiort O, Jüppner H, Kamenický P, Knight N, Le Norcy E, Lecumberri B, Levine MA, Mäkitie O, Martin R, Martos-Moreno GÁ, Minagawa M, Murray P, Pereda A, Pignolo R, Rejnmark L, Rodado R, Rothenbuhler A, Saraff V, Shoemaker AH, Shore EM, Silve C, Turan S, Woods P, Zillikens MC, Perez de Nanclares G, Linglart A. Mantovani G, et al. Horm Res Paediatr. 2020;93(3):182-196. doi: 10.1159/000508985. Epub 2020 Aug 5. Horm Res Paediatr. 2020. PMID: 32756064 Free PMC article. Review.
Patients affected by pseudohypoparathyroidism (PHP) or related disorders are characterized by physical findings that may include brachydactyly, a short stature, a stocky build, early-onset obesity, ectopic ossifications, and neurodevelopmental deficits, as well as hormonal …
Patients affected by pseudohypoparathyroidism (PHP) or related disorders are characterized by physical findings that may include brac …
Epidemiology and Diagnosis of Hypoparathyroidism.
Clarke BL, Brown EM, Collins MT, Jüppner H, Lakatos P, Levine MA, Mannstadt MM, Bilezikian JP, Romanischen AF, Thakker RV. Clarke BL, et al. J Clin Endocrinol Metab. 2016 Jun;101(6):2284-99. doi: 10.1210/jc.2015-3908. Epub 2016 Mar 4. J Clin Endocrinol Metab. 2016. PMID: 26943720 Free PMC article. Review.
CONTEXT: Hypoparathyroidism is a disorder characterized by hypocalcemia due to insufficient secretion of PTH. Pseudohypoparathyroidism is a less common disorder due to target organ resistance to PTH. This report summarizes the results of the findings and recommendations of …
CONTEXT: Hypoparathyroidism is a disorder characterized by hypocalcemia due to insufficient secretion of PTH. Pseudohypoparathyroidism
Pseudohypoparathyroidism.
Cianferotti L, Brandi ML. Cianferotti L, et al. Minerva Endocrinol. 2018 Jun;43(2):156-167. doi: 10.23736/S0391-1977.17.02768-7. Epub 2017 Nov 10. Minerva Endocrinol. 2018. PMID: 29125274 Review.
The term pseudohypoparathyroidism (PHP) refers to a spectrum of rare disorders of mineral metabolism, characterized by features due to end-organ resistance to PTH. ...
The term pseudohypoparathyroidism (PHP) refers to a spectrum of rare disorders of mineral metabolism, characterized by features due t …
Acrodysostosis.
Silve C, Clauser E, Linglart A. Silve C, et al. Horm Metab Res. 2012 Sep;44(10):749-58. doi: 10.1055/s-0032-1316330. Epub 2012 Jul 19. Horm Metab Res. 2012. PMID: 22815067 Review.
Finally, we will discuss the similarities and differences observed comparing patients with ADOHR and other diseases resulting from defects in the PTHR1 signaling pathway, in particular, pseudohypoparathyroidism type 1a and pseudopseudohypoparathyroidism....
Finally, we will discuss the similarities and differences observed comparing patients with ADOHR and other diseases resulting from defects i …
Medical Hypoparathyroidism.
Siraj N, Hakami Y, Khan A. Siraj N, et al. Endocrinol Metab Clin North Am. 2018 Dec;47(4):797-808. doi: 10.1016/j.ecl.2018.07.006. Epub 2018 Oct 11. Endocrinol Metab Clin North Am. 2018. PMID: 30390814 Review.
Genetic conditions result in hypoparathyroidism as part of a syndrome or in isolation. Pseudohypoparathyroidism reflects a resistance to PTH. Infiltrative, metastatic, radiation destruction, mineral deposition, or idiopathic are uncommon causes of hypoparathyroidism. ...
Genetic conditions result in hypoparathyroidism as part of a syndrome or in isolation. Pseudohypoparathyroidism reflects a resistance …
Management of pseudohypoparathyroidism.
Germain-Lee EL. Germain-Lee EL. Curr Opin Pediatr. 2019 Aug;31(4):537-549. doi: 10.1097/MOP.0000000000000783. Curr Opin Pediatr. 2019. PMID: 31145125 Free PMC article. Review.
PURPOSE OF REVIEW: This review is timely given the 2018 publication of the first international Consensus Statement for the diagnosis and management of pseudohypoparathyroidism (PHP) and related disorders. The purpose of this review is to provide the knowledge needed to rec …
PURPOSE OF REVIEW: This review is timely given the 2018 publication of the first international Consensus Statement for the diagnosis and man …
326 results